Is the CD4/CD8 ratio a useful test for people with HIV?
Age and CD4 count have the greatest influence on life expectancy in the modern HIV treatment era
White blood cell changes on islatravir do not lead to a higher risk of infections
HIV-specific immune response unconnected to inflammation in people taking ART
Lower chances of survival for people whose CD4 count remains under 500, Polish researchers report
Low CD4/CD8 ratio predicts increased cancer risk in people with HIV
Increased risk of Kaposi’s sarcoma with low CD4/CD8 ratios and of non-Hodgkin lymphoma with high CD8 counts despite effective HIV treatment
Earlier treatment and higher CD4 counts linked to smaller HIV reservoir
Spanish studies highlight scale of late presentation and its consequences for treatment
